missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. Invitrogen™ Synapsin II Recombinant Rabbit Monoclonal Antibody (23GB4960), Invitrogen™
  7. 30087517

Invitrogen™ Synapsin II Recombinant Rabbit Monoclonal Antibody (23GB4960), Invitrogen™
GREENER_CHOICE

Rabbit Recombinant Monoclonal Antibody

Brand:  Invitrogen™ MA552744

 View more versions of this product

Product Code. 30087517

  • £387.00 / 100µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

Synapsins (synapsin I, II, III) are a family of synaptic vesicle phosphoproteins that have been implicated in modulation of neurotransmitter release and in synaptogenesis. Synapsin II (SYN2) is composed of two isoforms, synapsin IIa and IIb.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Synapsin II
Recombinant Monoclonal
Unconjugated
SYN2
2900074L19Rik; AI836018; AI841723; SYN2; synapsin 2; synapsin II; Synapsin-2; SYNII; SYNIIa; SYNIIb
Rabbit
Affinity chromatography
RUO
29179, 6854
-20°C
Liquid
Flow Cytometry, Western Blot, Immunocytochemistry
23GB4960
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
Q63537, Q92777
SYN2
A synthesized peptide derived from human Synapsin II (210-270AA).
100 μL
Primary
Human, Rat
Antibody
IgG
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.